Femasys Inc reports results for the quarter ended June 30 - Earnings Summary

• Femasys Inc FEMY.OQ reported a quarterly adjusted loss of 16 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -21 cents. The mean expectation of three analysts for the quarter was for a loss of 18 cents per share.

• Revenue rose 112.2% to $469.00 thousand from a year ago; analysts expected $1.02 million.

• Femasys Inc's reported EPS for the quarter was a loss of 16 cents​.

• The company reported a quarterly loss of $4.59 million.

• Femasys Inc shares had fallen by 8.6% this quarter and lost 19.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 5.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Femasys Inc is $7.00, about 87.4% above its last closing price of $0.88

This summary was machine generated from LSEG data August 8 at 08:18 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)